Efficacy of Noninvasive Radiofrequency in Attenuating Diabetic Neuropathic Pain
Sponsored by Cairo University
About this trial
Last updated 2 years ago
Study ID
Ms-399-2022
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
40 to 70 Years
All Sexes
Trial Timing
Ended 2 years ago
What is this trial about?
Peripheral neuropathy increases the prevalence of diabetic foot ulcers following a decrease in foot sensation. Therefore, the treatment of this disorder is very important.
What are the participation requirements?
Inclusion Criteria
* Age 40-70 years
* Type II DM with DPN (grade I-II) in lower limbs
* Duration of DM>5 years
* Visual Analog Scale (VAS) ≥3 in the feet
* Sensory impairments in the lower extremities
Exclusion Criteria
* Patient with previous stenting or surgical intervention of lower limb arterial system.
* Patients with previous history of DVT.
* Pregnancy
* Diabetic infectious wound
* Cardiac pacemaker presence
* Severe liver and kidney dysfunction or history of heart and lung disease.